The new anti-epileptic drugs: Their current role in the management of epilepsy

European Journal of Neurology

Volumn 3, Issue SUPPL. 3, 1996, Pages 15-20

  Sander, J W A S ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c Epilepsy Research Group   (United Kingdom)

Author keywords

Anti epileptic drugs; Epilepsy; Gabapentin; Lamotrigine; Topiramate; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LAMOTRIGINE; NEW DRUG; TOPIRAMATE; VIGABATRIN;

BEHAVIOR DISORDER; CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; DROWSINESS; DRUG TOLERANCE; EPILEPSY; FATALITY; FOCAL EPILEPSY; HUMAN; LIVER FAILURE; LONG TERM CARE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROGNOSIS; RASH; TONIC CLONIC SEIZURE; UNITED KINGDOM; WEIGHT REDUCTION;

EID: 0029742812     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Alhassan MI, Bawazir SA, Alkhams KI, Matar KM, Tekle A (1993) The interaction potential of vigabatrin with phenytoin. Int J Pharmacol 93:7-12.
2. Annut H, Ashman P, Feuerstein TJ, et al. (1994) Gabapentin as add-on therapy in patients with partial seizures: a double blind, placebo controlled study. Epilepsia 35:795-801.
3. Appleton RE, Montiel-Viesca F (1993) Vigabatrin in infantile spasms - why add on? Lancet 341:962.
4. Ben-Menachem E (1995) Topiramate. In Antiepileptic Drugs. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; pp 1063-1070.
5. Binnie CD (1994) The efficacy of lamotrigine. Rev Contemp Pharmacother 5:115-122.
6. Brodie MJ, Pellock JM (1995) Taming the brain storms: felbamate updated. Lancet 346:918-919.
7. Brodie MJ, Richens A, Yuen AW (1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345:476-479.
8. Butler WH, Ford GP, Newberne JWA (1987) Study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-hooded rats. Toxicol Pathol 15:143-148.
9. Chadwick D (1995) Gabapentin: clinical use. In Antiepileptic Drugs. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; pp 851-856.
10. Chiron C, Dulac O, Luna D, et al. (1990) Vigabatrin in infantile spasms. Lancet 33:363-364.
11. Dulac O, Chiron C, Luna D, et al. (1991) Vigabatrin in childhood epilepsy. J Child Neurol 6 (suppl 2):S230-S237.
12. Gibson JP, Yarrington JT, Loudy DE, Gerbig CG, Hurst GH, Newberne JW (1987) Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor. Toxicol Pathol 18:225-238.
13. Hart YM, Sander JWAS (1994) The range of treatments for epilepsy. Rev Contemp Pharmacother 5:67-85.
14. Jolkonen J, Mazurkiewicz M, Lahtinen H, Riekkinen PJ (1992) Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis. Eur J Pharmacol 229:269-272.
15. Lippert B, Metcalf BW, Jung MJ, Casara P (1977) 4-amino-hex-5-enoic acid: a selective catalytic inhibitor of 4-aminobutyric-acid transferase in mammalian brain. Eur J Biochem 74:441-445.
16. Makin AJ, Fitt S, Williams R, Duncan JS (1995) Fulminant hepatic failure induced by lamotrigine [letter]. B M J 311:292.
17. McLean M (1995) Gabapentin: chemistry, absorption, distribution and excretion. In Antiepileptic Drugs. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; pp 843-849.
18. Meldrum BS (1979) Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition. In GABA-neurotransmitters-Alfred Benzon Symposium 12. Edited by Krogsgaard-Larsen P, Scheel-Kruger J, Kofod H. Copenhagen: Munksgaard; pp 390-405.
19. Meldrum B, Horton R (1978) Blockade of epileptic response in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, gamma-acetylenic GABA (4-amino-hex-5-ynoic acid) and gamma-vinyl GABA (4 amino-hex-5-enoic acid). Psychopharmacology 59:47-50.
20. Meldrum BS, Leach M (1994) The mechanism of action of lamotrigine. Rev Contemp Pharmacother 5:107-114.
21. Patsalos PN, Sander JWAS (1994) CNS Drugs. Drug Saf 11:37-67.
22. Patsalos PN, Duncan JS (1993) Antiepileptic drugs: a review of clinically significant interactions. Drug Saf 9:156-184.
23. Peck A (1994) Lamotrigine: historical background. Rev Contemp Pharmacother 5:95-105.
24. Pitkänen A, Ylinen A, Matilainen R, et al. (1993) Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients: a 5-year follow-up study. Arch Neurol 50:24-29.
25. Richens A (1992) Lamotrigine. In Recent Advances in Epilepsy, Vol. 5. Edited by Pedley T, Meldrum BS. Edinburgh: Churchill Livingstone; pp 197-210.
26. RichensA (1995) Lamotrigine: toxicity. In Antiepileptic Drugs. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; pp 897-902.
27. Riekkinen PJ, Ylinen A, Halonen T, et al. (1989) Cerebrospinal fluid GABA and seizure control with vigabatrin. Br J Clin Pharmacol 27 (suppl 1):87S-94S.
28. Rundfeldt C, Loscher W (1992) Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats. Eur J Pharmacol 213:351-366.
29. Sander JWAS (1993) Some aspects of the prognosis of the epilepsies: a review. Epilepsia 34:1007-1016.
30. Sander JWAS, Hart YM (1990) Vigabatrin and behaviour disturbance [letter]. Lancet 335:57.
31. Sander JWAS, Trevisol-Bittencourt PC, Hart YM, Shorvon SD (1990) Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. J Neurol Neurosurg Psychiatry 53:1008-1010.
32. Sander JWAS, Shorvon SD (1991) Vigabatrin treatment of epilepsy. Neurology 41:1854-1855.
33. Sander JWAS, Hart YM, Patsalos PN, Duncan JS, Shorvon SD (1991a) Lamotrigine and generalised seizures. Epilepsia 32 (suppl 1):59.
34. Sander JWAS, Hart YM, Trimble MR, Shorvon SD (1991b) Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 54:435-439.
35. Sander JWAS, Duncan JS (1996) Vigabatrin. In The treatment of epilepsy. Edited by Shorvon SD, Dreifuss FE, Fish DR, Thomas DGT. Oxford: Blackwell; pp 491-499.
36. Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ (1991) Vigabatrin in drug resistant partial epilepsy: a 5 year follow-up study. Neurology 41:562-565.
37. Taylor C (1995) Gabapentin: mechanism of action. In Antiepileptic Drugs. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; pp 829-841.
38. Timmins P, Richens A (1992) Lamotrigine in primary generalised epilepsy. Lancet 339:1300-1301.
39. UK Gabapentin Study Group (1990) Gahapentin in partial epilepsy. Lancet i:1114-1117.
40. US Gabapentin Study Group (1993) Gabapentin as an add-on therapy in refractory epilepsy. Neurology 43:2292-2298.
41. Walker MC, Sander JWAS (1996) The impact of new antiepileptic drugs on the prognosis of epilepsy: total seizure control should be the ultimate goal. Neurology 46:912-914.